October 26, 2016 5:43 AM ET


Company Overview of Calixa Therapeutics, Inc.

Executive Profile

Michael W. Bonney B.A.

Chief Executive Officer of Cubist, Calixa Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 11 different industries.

See Board Relationships


Mr. Michael W. Bonney, also known as Mike, B.A., was a Partner at Third Rock Ventures, LLC. Mr. Bonney served as the Chief Executive Officer of Cubist Pharmaceuticals Inc. from June 11, 2003 to December 31, 2014 and served as its President from January 2002 to July 2, 2012 and Chief Operating Officer from January 2002 to June 2003. He was employed at Biogen Idec MA Inc. He served as the Chief Executive Officer and President of TerraGen Discovery, Inc. since June 11, ...

Corporate Headquarters

12481 High Bluff Drive
San Diego, California 92130

United States

Phone: 858-480-2420
Fax: 877-393-3519

Board Members Memberships

Trustee, Chairman of Governance & Nominating Committee and Member of Valuation Committee
Independent Trustee, Chairman of Governance & Nominating Committee and Member of Valuation Committee
Chairman and Member of Audit Committee
Director and Member of Audit Committee
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee


Bates College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Calixa Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.